512-334-3505 (Option 1) 

Does Your Child Have 
Type 1 Diabetes?

Consider participating in a clinical research trial to improve possible treatment options for children around the world. 


...or fill out our contact form here.

Purpose of Study:

To test the effect of treatment with meal-time faster-acting insulin novolog on blood sugar control in children/teens. 


  • Male or female, ages 1 to 17 years of age
  • Diagnosed with type 1 diabetes
  • Ongoing daily treatment with a basal-bolus insulin regimen for at least 90 days
  • HbA1c < 9.5%

What are the benefits while participating in this trial?

Comprehensive Health Checks
& Medical Testing
Access to Trial Medication
& Blood Glucose Testing Equipment
You May Be Compensated
For Your Time & Travel